Invitrogen Corp Sample Contracts

MORPHAGEN, INC. STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
AutoNDA by SimpleDocs
AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • July 10th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
by and among
Registration Rights Agreement • March 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
SERVICE AGREEMENT
Service Agreement • March 21st, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances)
INDENTURE DATED AS OF DECEMBER 11, 2001
Invitrogen Corp • March 11th, 2002 • Biological products, (no disgnostic substances) • New York
EXHIBIT 2.1 ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • April 11th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
UNDERWRITING AGREEMENT
Underwriting Agreement • October 22nd, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
AND
Rights Agreement • March 30th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
3,500,000 Shares
Underwriting Agreement • January 28th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
PURCHASE AGREEMENT
Purchase Agreement • March 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances)
ARTICLE 1 TERM OF AGREEMENT
Employment Agreement • September 14th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
LICENSE AGREEMENT (SK# 2302)
License Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
500,000,000 2 1/4% CONVERTIBLE SUBORDINATED NOTES DUE 2006 REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 11th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • July 10th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
by and among
Patent License Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances)
INDENTURE
Invitrogen Corp • March 14th, 2000 • Biological products, (no disgnostic substances) • New York
UNDERWRITING AGREEMENT
Underwriting Agreement • December 10th, 1998 • Invitrogen Corp • New York
AutoNDA by SimpleDocs
CREDIT AGREEMENT dated as of February 14, 2012 among LIFE TECHNOLOGIES CORPORATION, as U.S. Borrower, APPLIED BIOSYSTEMS FINANCE B.V., LIFE TECHNOLOGIES EUROPE B.V., and LIFE TECHNOLOGIES FINANCE LIMITED, as Foreign Borrowers, THE LENDERS FROM TIME TO...
Credit Agreement • February 14th, 2012 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York

Credit Agreement (“Agreement”) dated as of February 14, 2012 among LIFE TECHNOLOGIES CORPORATION, a Delaware corporation (the “U.S. Borrower”), APPLIED BIOSYSTEMS FINANCE B.V., a company organized under the laws of the Netherlands (“ABFBV”), LIFE TECHNOLOGIES EUROPE B.V., a company organized under the laws of the Netherlands (“LTEBV”), LIFE TECHNOLOGIES FINANCE LIMITED, a company organized under the laws of Scotland (“LTFLTD”), each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”) and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.

RECITALS
Agreement • July 9th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • Wisconsin
CREDIT AGREEMENT dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, THE LENDERS FROM TIME TO TIME PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY...
Credit Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York

Credit Agreement (“Agreement”) dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY SENIOR FUNDING, INC. as Co-Syndication Agents, and DnB NOR BANK ASA and THE BANK OF NOVA SCOTIA, as Co-Documentation Agents.

CHANGE-IN-CONTROL AGREEMENT
Change-in-Control Agreement • March 2nd, 2007 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware

This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and [Name] (the “Executive”), dated as of the th Day of , 20 .

AMENDMENT TO CHANGE IN CONTROL AGREEMENT
Change in Control Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances)

THIS AMENDMENT to the CHANGE-IN-CONTROL AGREEMENT (the “Amendment”) is made and entered into as of November 21, 2008, by and between INVITROGEN CORPORATION, a Delaware corporation (the “Company”) and David F. Hoffmeister (“Executive”).

Contract
Registration Rights Agreement • June 24th, 2005 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York

This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 20, 2005 by and among Invitrogen Corporation, a Delaware corporation (the “Company”), and UBS Securities LLC (“UBS”) and Banc of America Securities LLC (“BoA”) (each an “Initial Purchaser” and together, the “Initial Purchasers”). The Company proposes to issue and sell to the Initial Purchasers (the “Initial Placement”) $325,000,000 in aggregate principal amount of its 3.25% Convertible Senior Notes due 2025 (the “Firm Convertible Notes”). The Company also proposes to issue and sell to the Initial Purchasers not more than $25,000,000 in aggregate principal amount of its 3.25% Convertible Senior Notes due 2025 (the “Additional Convertible Notes” and, together with the Firm Convertible Notes, the “Notes”) to cover over-allotments. As an inducement to the Initial Purchasers to enter into the purchase agreement, dated as of June 14, 2005 (the “Purchase Agreement”), and in satisfaction of a condition to

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!